Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
PREZZO DELLE AZIONI
SecurityDE:HVE / Innoviva, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership3,060,377 shares
Latest Disclosed Value $ 71,306,784
State Street Corp reports 9.42% increase in ownership of HVE / Innoviva, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 3,060,377 shares of Innoviva, Inc. (DE:HVE) valued at $61,207,540 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,796,820 shares of Innoviva, Inc.. This represents a change in shares of 9.42% during the quarter. The current value of the position is $58,759,238 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INNOVIVA COM 45781M101 3,060,377 263,557 9.42 71,307 27.54 0.0025
2026-02-13 2025-12-31 13F INNOVIVA COM 45781M101 2,796,820 239,848 9.38 55,908 19.81 0.0019
2025-11-14 2025-09-30 13F INNOVIVA COM 45781M101 2,556,972 99,510 4.05 46,665 -5.48 0.0016
2025-08-14 2025-06-30 13F INNOVIVA COM 45781M101 2,457,462 93,691 3.96 49,370 15.20 0.0019
2025-05-15 2025-03-31 13F INNOVIVA COM 45781M101 2,363,771 -94,899 -3.86 42,855 0.46 0.0018
2025-02-14 2024-12-31 13F INNOVIVA COM 45781M101 2,458,670 8,036 0.33 42,658 -9.86 0.0017
2024-11-14 2024-09-30 13F INNOVIVA COM 45781M101 2,450,634 -17,860 -0.72 47,322 16.89 0.0019
2024-08-14 2024-06-30 13F INNOVIVA COM 45781M101 2,468,494 -37,499 -1.50 40,483 6.00 0.0018
2024-05-15 2024-03-31 13F INNOVIVA COM 45781M101 2,505,993 2,134,837 575.19 38,191 2,440.98 0.0017
2024-02-14 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 371,156 2,496 0.68 1,503 51.66 0.0001
2024-02-14 2023-12-31 13F INNOVIVA COM 45781M101 2,518,778 150,465 40,401 0.0020
2023-11-14 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 368,660 1,144 0.31 992 -71.09 0.0001
2023-11-14 2023-09-30 13F INNOVIVA COM 45781M101 2,368,313 -13,444 30,764 0.0017
2023-08-14 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 367,516 70,652 23.80 3,429 30.05 0.0002
2023-08-14 2023-06-30 13F INNOVIVA COM 45781M101 2,381,757 -2,047 30,320 0.0016
2023-05-15 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 296,864 25,383 9.35 2,636 95.11 0.0001
2023-05-15 2023-03-31 13F INNOVIVA COM 45781M101 2,383,804 129,816 26,818 0.0015
2023-05-15 2022-12-31 13F/A-99 THESEUS PHARMACEUTICALS COM 88369M101 271,481 23,200 9.34 1,352 -6.18 0.0001
2023-05-15 2022-12-31 13F/A-99 INNOVIVA COM 45781M101 2,253,988 -216,906 29,865 0.0018
2023-05-15 2022-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 271,481 23,200 1,352 0.0001
2023-05-15 2022-12-31 13F INNOVIVA COM 45781M101 2,253,988 -216,906 29,865 0.0018
2022-11-15 2022-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 248,281 14,388 6.15 1,440 11.37 0.0001
2022-11-15 2022-09-30 13F INNOVIVA COM 45781M101 2,470,894 13,786 28,687 0.0018
2022-08-15 2022-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 233,893 51,232 28.05 1,293 -38.60 0.0001
2022-08-15 2022-06-30 13F INNOVIVA COM 45781M101 2,457,108 445,546 36,267 0.0022
2022-05-16 2022-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 182,661 55,865 44.06 2,106 30.97 0.0001
2022-05-16 2022-03-31 13F INNOVIVA COM 45781M101 2,011,562 -195,546 38,924 0.0019
2022-02-14 2021-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 126,796 -2,096,930 -94.30 1,608 -95.67 0.0001
2022-02-14 2021-12-31 13F INNOVIVA COM 45781M101 2,207,108 -16,618 38,073 0.0018
2021-11-15 2021-09-30 13F INNOVIVA COM 45781M101 2,223,726 -197,971 -8.17 37,158 14.42 0.0020
2021-08-16 2021-06-30 13F INNOVIVA COM 45781M101 2,421,697 90,014 3.86 32,475 16.55 0.0017
2021-07-09 2021-03-31 13F/A-1 INNOVIVA COM 45781M101 2,331,683 144,040 6.58 27,864 2.80 0.0016
2021-05-17 2021-03-31 13F INNOVIVA COM 45781M101 2,331,683 144,040 27,864 0.0016
2021-02-16 2020-12-31 13F INNOVIVA COM 45781M101 2,187,643 39,016 1.82 27,105 20.72 0.0017
2020-11-10 2020-09-30 13F INNOVIVA COM 45781M101 2,148,627 -137,840 -6.03 22,453 -29.76 0.0015
2020-08-14 2020-06-30 13F INNOVIVA COM 45781M101 2,286,467 82,933 3.76 31,965 23.35 0.0023
2020-06-19 2020-03-31 13F/A-1 INNOVIVA COM 45781M101 2,203,534 142,745 6.93 25,914 -11.20 0.0023
2020-05-11 2020-03-31 13F INNOVIVA COM 45781M101 2,203,534 142,745 25,914 2,275.7710
2020-02-06 2019-12-31 13F INNOVIVA COM 45781M101 2,060,789 -30,551 -1.46 29,181 32.38 0.0020
2019-11-14 2019-09-30 13F INNOVIVA COM 45781M101 2,091,340 -91,837 -4.21 22,043 -30.65 0.0016
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 2,183,177 -141,757 -6.10 31,787 -2.55 0.0024
2019-05-15 2019-03-31 13F INNOVIVA COM 45781M101 2,324,934 23,755 1.03 32,619 -18.77 0.0025
2019-02-12 2018-12-31 13F INNOVIVA COM 45781M101 2,301,179 -112,107 -4.65 40,156 9.19 0.0037
2018-11-09 2018-09-30 13F INNOVIVA Common equity shares 45781M101 2,413,286 15,877 0.66 36,776 11.16 0.0028
2018-08-14 2018-06-30 13F INNOVIVA Common equity shares 45781M101 2,397,409 52,572 2.24 33,085 -15.36 0.0028
2018-05-15 2018-03-31 13F INNOVIVA Common equity shares 45781M101 2,344,837 -103,313 -4.22 39,091 12.53 0.0033
2018-02-14 2017-12-31 13F INNOVIVA Common equity shares 45781M101 2,448,150 138,226 5.98 34,737 6.50 0.0028
2017-11-14 2017-09-30 13F INNOVIVA Common equity shares 45781M101 2,309,924 -407,331 -14.99 32,617 -6.22 0.0028
2017-08-14 2017-06-30 13F INNOVIVA Common equity shares 45781M101 2,717,255 348,584 14.72 34,782 6.17 0.0031
2017-05-15 2017-03-31 13F INNOVIVA Common equity shares 45781M101 2,368,671 257,381 12.19 32,760 45.00 0.0029
2017-02-09 2016-12-31 13F INNOVIVA Common equity shares 45781M101 2,111,290 274,320 14.93 22,593 11.91 0.0021
2017-01-13 2016-09-30 13F/A-1 INNOVIVA Common equity shares 45781M101 1,836,970 -71,396 -3.74 20,188 0.48 0.0020
2016-11-14 2016-09-30 13F INNOVIVA Common equity shares 45781M101 1,836,970 20,188
2016-08-12 2016-06-30 13F INNOVIVA Common equity shares 45781M101 1,908,366 95,725 5.28 20,092 -11.95 0.0022
2016-05-20 2016-03-31 13F/A-1 INNOVIVA Common equity shares 45781M101 1,812,641 -325,241 -15.21 22,820 1.29 0.0025
2016-05-12 2016-03-31 13F INNOVIVA Common equity shares 45781M101 1,812,641 22,820
2016-02-16 2015-12-31 13F INNOVIVA Common equity shares 45781M101 2,137,882 -1,089,904 -33.77 22,530 -2.78 0.0025
2015-11-16 2015-09-30 13F THERAVANCE Common equity shares 88338T104 3,227,786 213,355 7.08 23,174 -57.46 0.0027
2015-08-13 2015-06-30 13F THERAVANCE Common equity shares 88338T104 3,014,431 -295,691 -8.93 54,471 4.68 0.0058
2015-05-15 2015-03-31 13F THERAVANCE Common equity shares 88338T104 3,310,122 -362,366 -9.87 52,035 0.13 0.0053
2015-02-11 2014-12-31 13F THERAVANCE Common equity shares 88338T104 3,672,488 663,009 22.03 51,966 1.03 0.0052
2014-11-12 2014-09-30 13F/A-1 THERAVANCE Common equity shares 88338T104 3,009,479 473,586 18.68 51,434 -31.90 0.0055
2014-11-10 2014-09-30 13F THERAVANCE Common equity shares 88338T104 3,009,479 51,434
2014-08-12 2014-06-30 13F THERAVANCE Common equity shares 88338T104 2,535,893 1,159,555 84.25 75,522 77.35 0.0082
2014-05-15 2014-03-31 13F/A-1 THERAVANCE Common equity shares 88338T104 1,376,338 119,296 9.49 42,583 -4.98 0.0048
2014-05-13 2014-03-31 13F THERAVANCE Common equity shares 88338T104 1,377,263 42,612
2014-02-06 2013-12-31 13F/A-1 THERAVANCE Common equity shares 88338T104 1,257,042 -65,961 -4.99 44,817 -17.15 0.0050
2014-02-06 2013-12-31 13F THERAVANCE Common equity shares 88338T104 1,791,961 39,905
2013-11-12 2013-09-30 13F THERAVANCE Common Stock 88338T104 1,323,003 72,089 5.76 54,093 12.23 0.0067
2013-08-08 2013-06-30 13F THERAVANCE Common Stock 88338T104 1,250,914 1,250,914 48,199 0.0063
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.